WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
China Development Bank doubles loan support for farmland workSri Lanka witnesses rise in dengue cases with over 10,000 reported in DecemberIowa Supreme Court overturns $790,000 sexual harassment award to government employeeSports equipment exports from Yiwu to France surge 70 percent ahead of Paris OlympicsThailand: Water guns in full blast to mark New Year festivitiesManufacturing PMI expands in MarchAt least three people dead in shooting on university campus in Las Vegas14 dead in road accident in IndiaEthiopia says ready to play constructive role as new BRICS memberOutlook for China's energy transition released at COP28